共 40 条
[1]
BATATA MA, 1982, CANCER-AM CANCER SOC, V49, P1023, DOI 10.1002/1097-0142(19820301)49:5<1023::AID-CNCR2820490528>3.0.CO
[2]
2-M
[3]
BATIST G, 1986, J BIOL CHEM, V261, P5544
[4]
Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9
[6]
DECLON PC, 1987, BIOCHEM PHARMACOL, V36, P1955
[7]
EINHORN LH, 1980, CANCER, V46, P1339, DOI 10.1002/1097-0142(19800915)46:6<1339::AID-CNCR2820460607>3.0.CO
[8]
2-J
[9]
CISPLATIN-BASED CHEMOTHERAPY DOES NOT ELIMINATE THE RISK OF A 2ND TESTICULAR CANCER
[J].
BRITISH JOURNAL OF UROLOGY,
1989, 63 (05)
:531-534
[10]
GONDOS B, 1987, SEMIN DIAGN PATHOL, V4, P292